1059P 18F-FDG-PET/CT response assessment in patients with advanced melanoma treated with combination of low-dose ipilimumab and anti-PD1: A real-world experience

Autor: De Liz, C.D., Teixeira, M., Mendes Gomes, L.B., Rinck, J.A., Jr., Lima, J.P.S., Tavares, M.C., Garcia, D., Oliveira, T.B., Silva, M.B.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S883-S883
Databáze: ScienceDirect